Status:
UNKNOWN
Evaluation of Transnasal Endoscopy During COVID-19 Pandemic
Lead Sponsor:
Johannes Gutenberg University Mainz
Conditions:
Endoscopy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is n...
Detailed Description
COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing st...
Eligibility Criteria
Inclusion
- Indication for transnasal endoscopy
Exclusion
- pregnancy
- breast feeding
- contraindication to transnasal endoscopy
- pronounced blood clotting disorders
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04734912
Start Date
January 13 2021
End Date
December 31 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Mainz
Mainz, Rhenanie-Palatinate, Germany, 55131